Surgical Innovations Group updated the market on its current trading and its outlook for the current year on Friday, reporting that it was experiencing delays in the supply of products for its UK distribution business, Elemental Healthcare, sourced from Meccellis Biotech.
Medical technology company Surgical Innovations Group reported "strong" financial results for the year ended 31 December on Tuesday.
Surgical Innovations announced on Monday that its subsidiary Elemental Healthcare has signed a three year distribution deal with a Swiss company.
Medical technology firm Surgical Innovations (SI) announced on Wednesday that it had seen a welcome gain in revenue over its first half of trading thanks to a strong performance by its manufacturing (OEM) division and increased domestic sales.
Medical technology designer and manufacturer Surgical Innovations Group is planning to acquire specialist medical products distributor Elemental Healthcare, it announced on Thursday, in a deal worth £7.5m in cash and £1.875m in consideration shares.
Shares in Surgical Innovations rose more than 8% after it returned to full-year pre-tax profit.
Medical technology manufacturer Surgical Innovations Group has bought a laparoscopic instruments business from Surgical Dynamics for about £360,000, including assumed debt of not greater than £50,000.
Designer and manufacturer of medical technology Surgical Innovations Group announced on Wednesday that its new laparoscopic port access system, YelloPort Elite, has attained CE certification.
The chief executive of British Polythene Industries has sold £0.35m-worth of shares in the plastic bag maker.
Surgical Innovations Limited, which is a subsidiary of Surgical Innovations Group, has entered into a distribution deal with Asia Cardiovascular Products Ltd.
Shares in Surgical Innovations were boosted after the company said it appointed a new finance director.
Shares in Surgical Innovation tumbled after it warned that following a recent review its full year revenues would be around £0.6m lower than previously anticipated.
It was a disappointing first half performance for Surgical Innovations Group, which blamed a significant drop in profit on an impairment charge resulting from its decision to focus on sustainable long-term growth in its SI brand business.
AIM-listed Surgical Innovations Group has warned that both its revenue and profit will be "significantly below market expectations" for the full year.
AIM-listed medical group Surgical Innovations announced it has secured a 3m pound banking facility from Yorkshire Bank's Business and Private Banking Centre in Leeds.
The mobile telecoms and healthcare categories were putting in decent performances on Thursday in London after results from sector heavyweights Vodafone and Smith & Nephew impressed.
Shares in Surgical Innovations declined sharply after the company warned its profits had been hit by the US dollar exchange rate and its investment during the second half.
Aberdeen Asset Management: JP Morgan cuts target price from 544p to 529p, while its overweight rating remains unchanged. Canaccord Genuity reduces target price from 586p to 540p and reiterates a buy recommendation. UBS lowers target price from 540p to 520p and keeps a buy recommendation.
African Barrick Gold: Investec shifts target price from 135p to 137p, while downgrading from hold to sell.
Keyhole surgery equipment specialist Surgical Innovations sold more of its own branded products in the first half, leading to a strong rise in profits.